Kanagawa, Japan

Shusuke Furuyama



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shusuke Furuyama: Innovator in Diazabicyclooctane Derivatives

Introduction

Shusuke Furuyama is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the production of diazabicyclooctane derivatives. With a total of 2 patents to his name, Furuyama's work is recognized for its innovative approaches and practical applications.

Latest Patents

Furuyama's latest patents include a process for producing crystals of a diazabicyclooctane derivative. This process involves crystallizing the compound from an aqueous solution containing the compound and an inorganic salt, such as sodium chloride. The resulting crystals can be subjected to lyophilization, providing a lyophilized composition with desirable storage stability. Another patent focuses on the lyophilized composition of a diazabicyclooctane compound and the process of producing the same, emphasizing the importance of stability in storage.

Career Highlights

Furuyama is currently associated with Meiji Seika Pharma Co., Ltd., where he continues to innovate and develop new chemical processes. His work has contributed to advancements in pharmaceutical applications, showcasing his expertise in the field.

Collaborations

Furuyama collaborates with talented individuals such as Takaya Ogawa and Takuya Yokoyama. Their combined efforts enhance the research and development initiatives within their organization.

Conclusion

Shusuke Furuyama is a distinguished inventor whose work in diazabicyclooctane derivatives has made a significant impact in the field of chemistry. His innovative processes and collaborations continue to drive advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…